Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2011-04-12
2011-04-12
Ouspenski, Ilia (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reexamination Certificate
active
07923009
ABSTRACT:
A medicament based on antibodies contains an activated form of ultra-low doses of monoclonal, polyclonal, or natural antibodies to the prostate-specific antigen, the activated form being prepared by multiple consecutive dilutions and exposure to external factors, preferably according to homeopathic technology. In order to obtain the antibodies, the prostate-specific antigen isolated from the prostatic tissues of cattle or prepared synthetically is employed; a mixture of various, mostly centesimal, homeopathic dilutions is used. The method of treating diseases of the urogenital sphere consists in using activated forms of ultra-low doses of antibodies to prostate-specific antigen prepared by multiple consecutive dilutions and exposure to external factors.
REFERENCES:
patent: 4963367 (1990-10-01), Ecanow
patent: 5629286 (1997-05-01), Brewitt
patent: 5683712 (1997-11-01), Cavazza
patent: 5698195 (1997-12-01), Le et al.
patent: 5741488 (1998-04-01), Feldman
patent: 5895783 (1999-04-01), Garfield et al.
patent: 6150500 (2000-11-01), Salerno
patent: 6326360 (2001-12-01), Kanazawa et al.
patent: 6750197 (2004-06-01), Salerno
patent: 7572441 (2009-08-01), Epshtein et al.
patent: 7582294 (2009-09-01), Epshtein et al.
patent: 2002/0001588 (2002-01-01), Sinha
patent: 2003/0099636 (2003-05-01), Epshtein et al.
patent: 2006/0165697 (2006-07-01), Epshtein et al.
patent: 2007/0123518 (2007-05-01), Epshtein
patent: 0652014 (1995-05-01), None
patent: 0687466 (1995-12-01), None
patent: 2007989 (1994-02-01), None
patent: 2033784 (1995-04-01), None
patent: 2104032 (1998-02-01), None
patent: 2122858 (1998-12-01), None
patent: 2137483 (1999-09-01), None
patent: 2144370 (2000-01-01), None
patent: 98109384 (2000-03-01), None
patent: 2191601 (2002-10-01), None
patent: 1730144 (1992-04-01), None
patent: 9412213 (1994-06-01), None
patent: 9422846 (1994-10-01), None
patent: 0105371 (2001-01-01), None
patent: 03037372 (2003-08-01), None
patent: 03055519 (2003-10-01), None
Vyazov, O.L., Laboratory Methods of Studies in Non-Infection Immunology (in Russian)m Moscow, Meditsina, 1968.
Marsden, P.A. et al., “Molecular cloning and characterization of human endothelial nitric oxide synthase,” FEBS Lett., vol. 307, No. 3, pp. 287-293, 1992.
Frimel, G., ed., “Immunological Methods,” Medicina Publishing House, 1987, pp. 9-33.
Register of Pharmaceuticals of Russia, Encyclopedia of Pharmaceuticals (in Russian), Moscow, 2000, pp. 358-359.
Register of Pharmaceuticals of Russia, Encyclopedia of Pharmaceuticals (in Russian), Moscow, 2001, pp. 788-789.
International Search Report from International Application No. PCT/RU97/00026, filed Feb. 10, 1997, mailed on Apr. 8, 1997.
Grigoriev M. Yu. et al., “K probleme ispolzovaniya potentsirovannykh organnykh preparatov,” Lechebno-profilakticheskaja Rabota Dlya Meditsinskikh Organizatsij V Ugolnoj Promyshlennosti, vyp. 8, 1989, izd. Tsniehi ugol (Moscow), pp. 163-165.
Ivaniushkin, A. Ja., “Gomeopatiya i sovremennaya meditsina,” Vestnik Akademii Meditsinskikh Nauk SSSR, 4, 1988, izd. “Meditsina” (Moscow), pp. 76-82.
Vasiliev, Yu, V. et al., “Gomeopatiya: vozrozhdenie traditsionnioy meditsinskoj shkoly,” Vestnik Rossijkoj Akademii Nauk, 10, 1992, izd. “Nauka” (Moscow), pp. 145-148.
Gaevy, M.D. et al., “Osnovy klinicheskoi farmakologii I farmakoterapii,” Moscow, Aliyans-B, 2002, pp. 42-44.
Schwab, V., “Homeopathic Pharmaceutical Agents. A manual on description and preparation,” Moscow, 1967, pp. 12-38.
Janeway et al. Immunobiology, 1997, 3rd edition, Garland Publishing Inc., pp. 3:1-3:11.
Davenas et al., Nature, 1988, 333: 816-818.
Epshtein et al. May 1999, Bulletin of Experimental Biology and Medicine,vol. 5: 493-495.
Sensabaugh, G.F. et al., “Seminal Plasma Protein p30: Simplified Purification and Evidence for Identity with Prostate Specific Antigen,”J. Urol., vol. 144, pp. 1523-1526, 1990.
Linde et al., 1997, Lancet, vol. 350: 834-43.
Shang et al., 2005, Lancet, vol. 366: 726-32.
Palace et al., 2003, J. Neur. Sci. vol. 206: 131-134.
Beregovoy et al., On influence of various Dilutions of Monoclonal Antibodies 5F5-B6 on the Formation of Long-Term Post-Tetanic Potentiation in Survived Hippocampal Slices, Bull of Siberian Branch of RAMS No. 1 (91), 1999.
Stefani, D. V. et al., “Immunologiya i immunopatologiya detskogo vozrasta,” Moscow, Meditsina, 1996, pp. 28, 29, 358-359.
International Search Report from International Application No. PCT/RU02/00368, filed Aug. 2, 2002, mailed on Dec. 5, 2002.
Alexandrova et al., “An Experience of Application of Potentiated Compounds for Jugulation of Alcohol Abstinent Syndrome and Opiate Abstinent Syndrome,” Bull of Siberian Branch of RAMS, No. 1 (91), 1999.
Borovskaya, et al., Impact of Antibodies to Endothelial No-Synthase on Sexual Behavior of Male Rats in Conditions of Seasonal Suppression of Reproductive Function, Scientific—Research Institute of pharmacology (2001) (Translation).
Schwabe, W., “German Homeopathic pharmacopoeia (Homeopathisches Arzneibuch),” Stuttgart, Translation of the 5th Supplement (1991) to the 1978 edition.
Goldacre (2007) Lancet 370: 1672-1673.
International Search Report from International Application No. PCT/RU02/00367, filed Aug. 2, 2002, mailed on Dec. 19, 2002.
International Search Report from International Application No. PCT/RU02/00369, filed Aug. 2, 2002, mailed on Dec. 19, 2002.
International Search Report from International Application No. PCT/RU01/00239, filed Jun. 19, 2001, mailed on Sep. 20, 2001.
International Search Report from International Application No. PCT/RU02/00365, filed Aug. 2, 2002, mailed on Dec. 5, 2002.
Kuznik, R.I. et al., “Cytomedines and their Role in Regulation of Physiological Functions,” Uspekhi Sovremennoi Biologii, 1995, vol. 115, No. 3, pp. 353-367.
Dygay Alexandr Mikhailovich
Epshtein Oleg Iliich
Goldberg Evgeny Danilovich
Kaplan Gilman & Pergament LLP
Ouspenski Ilia
LandOfFree
Medicinal agent and method for curing prostate diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicinal agent and method for curing prostate diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicinal agent and method for curing prostate diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2725508